Schedule 13G ownership disclosure

Epizyme, Inc.

Security class unavailable · CUSIP: 29428V104

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,659,104
Percent of class
15.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-019079
Form type
SC 13G
Filer
Epizyme, Inc.
CIK
CIK 1571498
Filed
Feb 12, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub